High levels of CD44 (a transmembrane hyaluronic acid receptor) were associated with a significant decrease in median survival in tissue specimens from 62 GBM patients (349), and CD44 inhibition reduced tumor growth in a mouse model of GBM (350). This evidence concerns the gene CD44 and glioblastoma.